Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice

Sean P. Dineen, Kristi D. Lynn, Shane E. Holloway, Andrew F. Miller, James P. Sullivan, David S. Shames, Adam W. Beck, Carlton C. Barnett, Jason B. Fleming, Rolf A. Brekken

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Macrophages are an abundant inflammatory cell type in the tumor microenvironment that can contribute to tumor growth and metastasis. Macrophage recruitment into tumors is mediated by multiple cytokines, including vascular endothelial growth factor (VEGF), which is thought to function primarily through VEGF receptor (VEGFR)1 expressed on macrophages. Macrophage infiltration is affected by VEGF inhibition. We show that selective inhibition of VEGFR2 reduced macrophage infiltration into orthotopic pancreatic tumors. Our studies show that tumor-associated macrophages express VEGFR2. Furthermore, peritoneal macrophages from tumor-bearing animals express VEGFR2, whereas peritoneal macrophages from non-tumor-bearing animals do not. To our knowledge, this is the first time that tumor-associated macrophages have been shown to express VEGFR2. Additionally, we found that the cytokine pleiotrophin is sufficient to induce VEGFR2 expression on macrophages. Pleiotrophin has previously been shown to induce expression of endothelial cell markers on macrophages and was present in the microenvironment of orthotopic pancreatic tumors. Finally, we show that VEGFR2, when expressed by macrophages, is essential for VEGF-stimulated migration of tumor-associated macrophages. In summary, tumor-associated macrophages express VEGFR2, and selective inhibition of VEGFR2 reduces recruitment of macrophages into orthotopic pancreatic tumors. Our results show an underappreciated mechanism of action that may directly contribute to the antitumor activity of angiogenesis inhibitors that block the VEGFR2 pathway.

Original languageEnglish (US)
Pages (from-to)4340-4346
Number of pages7
JournalCancer Research
Volume68
Issue number11
DOIs
StatePublished - Jun 1 2008

Fingerprint

Vascular Endothelial Growth Factor Receptor-2
Macrophages
Neoplasms
Vascular Endothelial Growth Factor A
Peritoneal Macrophages
Cytokines
Vascular Endothelial Growth Factor Receptor-1
Angiogenesis Inhibitors
Tumor Microenvironment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. / Dineen, Sean P.; Lynn, Kristi D.; Holloway, Shane E.; Miller, Andrew F.; Sullivan, James P.; Shames, David S.; Beck, Adam W.; Barnett, Carlton C.; Fleming, Jason B.; Brekken, Rolf A.

In: Cancer Research, Vol. 68, No. 11, 01.06.2008, p. 4340-4346.

Research output: Contribution to journalArticle

Dineen, SP, Lynn, KD, Holloway, SE, Miller, AF, Sullivan, JP, Shames, DS, Beck, AW, Barnett, CC, Fleming, JB & Brekken, RA 2008, 'Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice', Cancer Research, vol. 68, no. 11, pp. 4340-4346. https://doi.org/10.1158/0008-5472.CAN-07-6705
Dineen, Sean P. ; Lynn, Kristi D. ; Holloway, Shane E. ; Miller, Andrew F. ; Sullivan, James P. ; Shames, David S. ; Beck, Adam W. ; Barnett, Carlton C. ; Fleming, Jason B. ; Brekken, Rolf A. / Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. In: Cancer Research. 2008 ; Vol. 68, No. 11. pp. 4340-4346.
@article{715e558edb0e4592912e641d80decac1,
title = "Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice",
abstract = "Macrophages are an abundant inflammatory cell type in the tumor microenvironment that can contribute to tumor growth and metastasis. Macrophage recruitment into tumors is mediated by multiple cytokines, including vascular endothelial growth factor (VEGF), which is thought to function primarily through VEGF receptor (VEGFR)1 expressed on macrophages. Macrophage infiltration is affected by VEGF inhibition. We show that selective inhibition of VEGFR2 reduced macrophage infiltration into orthotopic pancreatic tumors. Our studies show that tumor-associated macrophages express VEGFR2. Furthermore, peritoneal macrophages from tumor-bearing animals express VEGFR2, whereas peritoneal macrophages from non-tumor-bearing animals do not. To our knowledge, this is the first time that tumor-associated macrophages have been shown to express VEGFR2. Additionally, we found that the cytokine pleiotrophin is sufficient to induce VEGFR2 expression on macrophages. Pleiotrophin has previously been shown to induce expression of endothelial cell markers on macrophages and was present in the microenvironment of orthotopic pancreatic tumors. Finally, we show that VEGFR2, when expressed by macrophages, is essential for VEGF-stimulated migration of tumor-associated macrophages. In summary, tumor-associated macrophages express VEGFR2, and selective inhibition of VEGFR2 reduces recruitment of macrophages into orthotopic pancreatic tumors. Our results show an underappreciated mechanism of action that may directly contribute to the antitumor activity of angiogenesis inhibitors that block the VEGFR2 pathway.",
author = "Dineen, {Sean P.} and Lynn, {Kristi D.} and Holloway, {Shane E.} and Miller, {Andrew F.} and Sullivan, {James P.} and Shames, {David S.} and Beck, {Adam W.} and Barnett, {Carlton C.} and Fleming, {Jason B.} and Brekken, {Rolf A.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1158/0008-5472.CAN-07-6705",
language = "English (US)",
volume = "68",
pages = "4340--4346",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice

AU - Dineen, Sean P.

AU - Lynn, Kristi D.

AU - Holloway, Shane E.

AU - Miller, Andrew F.

AU - Sullivan, James P.

AU - Shames, David S.

AU - Beck, Adam W.

AU - Barnett, Carlton C.

AU - Fleming, Jason B.

AU - Brekken, Rolf A.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Macrophages are an abundant inflammatory cell type in the tumor microenvironment that can contribute to tumor growth and metastasis. Macrophage recruitment into tumors is mediated by multiple cytokines, including vascular endothelial growth factor (VEGF), which is thought to function primarily through VEGF receptor (VEGFR)1 expressed on macrophages. Macrophage infiltration is affected by VEGF inhibition. We show that selective inhibition of VEGFR2 reduced macrophage infiltration into orthotopic pancreatic tumors. Our studies show that tumor-associated macrophages express VEGFR2. Furthermore, peritoneal macrophages from tumor-bearing animals express VEGFR2, whereas peritoneal macrophages from non-tumor-bearing animals do not. To our knowledge, this is the first time that tumor-associated macrophages have been shown to express VEGFR2. Additionally, we found that the cytokine pleiotrophin is sufficient to induce VEGFR2 expression on macrophages. Pleiotrophin has previously been shown to induce expression of endothelial cell markers on macrophages and was present in the microenvironment of orthotopic pancreatic tumors. Finally, we show that VEGFR2, when expressed by macrophages, is essential for VEGF-stimulated migration of tumor-associated macrophages. In summary, tumor-associated macrophages express VEGFR2, and selective inhibition of VEGFR2 reduces recruitment of macrophages into orthotopic pancreatic tumors. Our results show an underappreciated mechanism of action that may directly contribute to the antitumor activity of angiogenesis inhibitors that block the VEGFR2 pathway.

AB - Macrophages are an abundant inflammatory cell type in the tumor microenvironment that can contribute to tumor growth and metastasis. Macrophage recruitment into tumors is mediated by multiple cytokines, including vascular endothelial growth factor (VEGF), which is thought to function primarily through VEGF receptor (VEGFR)1 expressed on macrophages. Macrophage infiltration is affected by VEGF inhibition. We show that selective inhibition of VEGFR2 reduced macrophage infiltration into orthotopic pancreatic tumors. Our studies show that tumor-associated macrophages express VEGFR2. Furthermore, peritoneal macrophages from tumor-bearing animals express VEGFR2, whereas peritoneal macrophages from non-tumor-bearing animals do not. To our knowledge, this is the first time that tumor-associated macrophages have been shown to express VEGFR2. Additionally, we found that the cytokine pleiotrophin is sufficient to induce VEGFR2 expression on macrophages. Pleiotrophin has previously been shown to induce expression of endothelial cell markers on macrophages and was present in the microenvironment of orthotopic pancreatic tumors. Finally, we show that VEGFR2, when expressed by macrophages, is essential for VEGF-stimulated migration of tumor-associated macrophages. In summary, tumor-associated macrophages express VEGFR2, and selective inhibition of VEGFR2 reduces recruitment of macrophages into orthotopic pancreatic tumors. Our results show an underappreciated mechanism of action that may directly contribute to the antitumor activity of angiogenesis inhibitors that block the VEGFR2 pathway.

UR - http://www.scopus.com/inward/record.url?scp=47949097072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47949097072&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-6705

DO - 10.1158/0008-5472.CAN-07-6705

M3 - Article

C2 - 18519694

AN - SCOPUS:47949097072

VL - 68

SP - 4340

EP - 4346

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 11

ER -